Take Solutions Ltd

Next 500 2022
+ 7 More
+ 7 More
OVERVIEW
FINANCIALS

About

TAKE Solutions Limited is a Chennai-based contract research organisation (CRO) that provides end-to-end support to pharmaceutical, biotechnology and medical device companies worldwide. Originally founded as a supply chain management solutions company, TAKE pivoted to the life sciences sector following the 2008 global financial crisis, recognising the industry’s recession resistant potential. Under the brand Navitas Life Sciences, the company is primarily involved in the fields of clinical research, generics development, regulatory affairs, and pharmacovigilance. TAKE also offers services like clinical trials, regulatory compliance, and postmarketing safety. North America accounts for 2/3rds of the company’s revenue, making it TAKE’s largest market, followed by the Asia-Pacific Region.

Incorporation Year: 2000
Headquarters: Chennai, Tamil Nadu
Top Management: Srinivasan H.R.
Industry: Healthcare - Ancillary

Featured In Fortune India Ranking

#459(2020)
Next 500 India
#358(2022)#16(2020)#87(2019)#139(2018)#242(2017)#389(2016)#411(2015)
#358(2022)#16(2020)#87(2019)#139(2018)#242(2017)#389(2016)#411(2015)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
67
(INR Cr)
Net Operating Income
66
(INR Cr)
Assets
29
(INR Cr)
Profit
-120
(INR Cr)
Net Worth
-9
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
67
-66.0%
198
-70.6%
672
-14.8%
788
-64.8%
2239
9.3%
2050
28.6%
1594
17.4%
1357
29.2%
1051
42.3%
739
-10.1%
822
-2.0%
839
16.7%
719
42.0%
506
38.2%
366
6.7%
343
-
Net Operating Income
(INR Cr)
66
-65.30%
189
-71.14%
655
-15.35%
774
-65.02%
2213
8.53%
2039
28.46%
1587
18.05%
1345
30.52%
1030
41.03%
730
-10.44%
816
-1.97%
832
18.23%
704
40.65%
500
42.22%
352
4.87%
335
14.13%
Profit
(INR Cr)
-120
-
-100
-
-782
-
-452
-
-12
-
177
10.5%
160
12.2%
143
19.6%
120
71.2%
70
20.5%
58
-27.0%
79
-7.1%
86
22.3%
70
115.8%
32
-38.7%
53
-
Assets
(INR Cr)
29
-81.1%
156
-40.0%
260
-84.5%
1673
-23.4%
2185
9.1%
2003
20.4%
1663
38.3%
1202
18.0%
1019
27.7%
798
8.8%
733
9.6%
669
15.9%
577
21.8%
474
12.9%
420
2.5%
410
-
Net Worth
(INR Cr)
-9
-108.2%
109
-40.0%
181
-83.9%
1125
-28.6%
1575
3.8%
1518
14.3%
1328
45.8%
911
44.3%
631
20.4%
524
11.6%
470
11.8%
420
23.0%
342
34.3%
255
-30.4%
366
-0.7%
368
27.5%
Employee Cost
(INR Cr)
15
-68.8%
48
-84.5%
309
-34.7%
474
-34.1%
719
21.5%
592
32.4%
447
15.4%
387
37.4%
282
34.3%
210
-7.4%
227
0.7%
225
23.6%
182
31.0%
139
-1.9%
142
27.9%
111
-
Interest Cost
(INR Cr)
572937412521231513141418842
Cash & Bank Balance
(INR Cr)
11130394570341110128124777660464854
Total Debt
(INR Cr)
3746595145534743232373362092071961931853424

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues -----8.7%10.1%10.5%11.4%9.5%7.1%9.5%11.9%13.8%8.9%15.4%
Profit As % Of Assets -----8.9%9.7%11.9%11.7%8.8%7.9%11.9%14.8%14.8%7.7%12.9%
Profit As % Of Networth -----11.7%12.1%15.7%19.0%13.3%12.3%18.9%25.0%27.5%8.9%14.4%
Interest Cost to EBITDA % ----24.4%6.5%6.8%8.6%6.9%8.5%9.4%8.9%12.6%7.5%12.5%3.6%
Debt to Equity Ratio -0.430.320.460.350.310.240.260.530.400.440.470.560.730.090.06
RONW -----12.5%14.3%19.0%18.9%16.1%13.9%22.3%28.5%22.0%9.5%16.0%
ROCE 0.0%0.0%0.0%-9.2%1.4%13.2%14.8%17.6%16.4%13.8%11.7%20.3%25.4%19.6%10.8%16.7%